These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19811301)

  • 1. DNA-hydrolyzing Ab: is catalytic activity a clue for physiological significance?
    Kozyr AV; Gabibov AG
    Autoimmunity; 2009 May; 42(4):359-61. PubMed ID: 19811301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phenomenon of DNA-abzyme cross-reactivity and its significance for the mechanisms of cytotoxicity and apoptosis].
    Suchkov SV; Gabibov AG; Gnuchev NV
    Ontogenez; 2001; 32(5):348-52. PubMed ID: 11605407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies with enzymatic properties in human autoimmune diseases.
    Wootla B; Lacroix-Desmazes S; Warrington AE; Bieber AJ; Kaveri SV; Rodriguez M
    J Autoimmun; 2011 Sep; 37(2):144-50. PubMed ID: 21624820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic autoantibodies in clinical autoimmunity and modern medicine.
    Gabibov AG; Ponomarenko NA; Tretyak EB; Paltsev MA; Suchkov SV
    Autoimmun Rev; 2006 May; 5(5):324-30. PubMed ID: 16782557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases.
    Kozyr AV; Kolesnikov AV; Aleksandrova ES; Sashchenko LP; Gnuchev NV; Favorov PV; Kotelnikov MA; Iakhnina EI; Astsaturov IA; Prokaeva TB; Alekberova ZS; Suchkov SV; Gabibov AG
    Appl Biochem Biotechnol; 1998 Oct; 75(1):45-61. PubMed ID: 10214696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Catalytic autoantibodies in autoimmune myocarditis: clinical and pathogenetic implications].
    Kalinina EV; Ponomarenko NA; Durova OM; Paleev FN; Vorob'ev II; Kekenadze NN; Shogenov ZS; Zemtsova ME; Gnuchev NV; Gabibov AG
    Ter Arkh; 2005; 77(9):65-70. PubMed ID: 16281493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies and autoantigens: a conserved system that may shape a primary immunoglobulin gene pool.
    Stollar BD
    Mol Immunol; 1991 Dec; 28(12):1399-412. PubMed ID: 1749388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Achievements and prospects of clinical abzymology].
    Suchkov SV; Alekberova ZS; Paleev FN; Naumova TE; Misikov VK; Kriazheva ES; Ponomarenko NA; Gabivov AG
    Vestn Ross Akad Med Nauk; 2005; (9):38-43. PubMed ID: 16250330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Substrate specificity of serum DNA- and RNA-hydrolyzing antibodies of patients with polyarthritis and autoimmune thyroiditis].
    Vlasov AV; Baranovskiĭ AG; Kanyshkova TG; Prints AV; Zabara VG; Naumov VA; Breusov AA; Giege R; Buneva VN; Nevinskiĭ GA
    Mol Biol (Mosk); 1998; 32(3):559-69. PubMed ID: 9720080
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA-hydrolyzing antibodies from sera of autoimmune-prone MRL/MpJ-lpr mice.
    Dubrovskaya VV; Andryushkova AS; Kuznetsova IA; Toporkova LB; Buneva VN; Orlovskaya IA; Nevinsky GA
    Biochemistry (Mosc); 2003 Oct; 68(10):1081-8. PubMed ID: 14616078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Catalytic autoantibodies as a new molecular instrument in rheumatological practice].
    Khitrov AN; Mal'tsev KA; Vvedenskaia OIu; Ponomarenko NA; Isaeva MA; Kimova MV; Tret'iak EB; Shogenov ZS; Alekberova ZS; Gabibov AG; Suchkov SV
    Ter Arkh; 2006; 78(6):59-66. PubMed ID: 16881365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of apoptosis in autoimmunity: immunogen, antigen, and accelerant.
    Levine JS; Koh JS
    Semin Nephrol; 1999 Jan; 19(1):34-47. PubMed ID: 9952279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern aspects of immunopathogenesis of autoimmune myocarditis.
    Paleev FN; Kotova AA; Suchkov SV; Paleev NR
    Russ J Immunol; 2002 Dec; 7(4):323-7. PubMed ID: 12687243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["Functionality" of antibodies: clinical implications].
    Pal'tsev MA; Suchkov SV
    Ter Arkh; 2008; 80(8):68-75. PubMed ID: 18807546
    [No Abstract]   [Full Text] [Related]  

  • 15. Idiotypic induction of autoimmunity: do we need an autoantigen?
    Shoenfeld Y
    Clin Exp Rheumatol; 1994; 12 Suppl 11():S37-40. PubMed ID: 7768049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition of human autoimmunity--autoantibodies versus autoimmune disease.
    Lleo A; Invernizzi P; Gao B; Podda M; Gershwin ME
    Autoimmun Rev; 2010 Mar; 9(5):A259-66. PubMed ID: 19963079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease association and cytotoxic effects of DNA-hydrolyzing autoantibodies.
    Gabibov AG; Kozyr AV; Kolesnikov AV
    Chem Immunol; 2000; 77():130-56. PubMed ID: 11706703
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoantibodies and antibacterial antibodies: from both sides now.
    Watts RA; Isenberg DA
    Ann Rheum Dis; 1990 Dec; 49(12):961-5. PubMed ID: 2270967
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.
    Kerr JR
    J Clin Pathol; 2016 Apr; 69(4):279-91. PubMed ID: 26644521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell epitopes of the intracellular autoantigens Ro/SSA and La/SSB: tools to study the regulation of the autoimmune response.
    Routsias JG; Tzioufas AG
    J Autoimmun; 2010 Nov; 35(3):256-64. PubMed ID: 20643529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.